beta-Thromboglobulin and platelet factor 4 levels in a case of acute thrombotic thrombocytopenic purpura.
We have described a case of acute thrombotic thrombocytopenic purpura in which multiple therapeutic methods eventuated in recovery. We suggest that the ratio of the platelet marker proteins beta-thromboglobulin and platelet factor 4 may have value in the assessment of therapy and prognosis in following the clinical course of this disorder of platelets.
D K
DK
McRoyan
S J
SJ
Daniel
P I
PI
Liu
D000208:Acute Disease; D000328:Adult; D001609:Beta-Globulins / Q000032:analysis*; D003131:Combined Modality Therapy; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D010956:Plasmapheresis; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000032:analysis*; D011379:Prognosis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood* / Q000628:therapy; D013256:Steroids / Q000627:therapeutic use; D001620:beta-Thromboglobulin / Q000032:analysis*
D001609:Beta-Globulins; D005343:Fibrinolytic Agents; D013256:Steroids; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D007770:L-Lactate Dehydrogenase